These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31625189)

  • 1. Editorial: hepatocellular carcinoma in the absence of cirrhosis-a nightmare without solution.
    Ioannou GN
    Aliment Pharmacol Ther; 2019 Nov; 50(9):1062-1063. PubMed ID: 31625189
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence and risk factors of hepatocellular carcinoma in patients with primary biliary cirrhosis.
    Macaron C; Hanouneh IA; Zein NN
    Hepatology; 2010 Dec; 52(6):2239; author reply 2239-40. PubMed ID: 21105115
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection.
    Chayanupatkul M; Omino R; Mittal S; Kramer JR; Richardson P; Thrift AP; El-Serag HB; Kanwal F
    J Hepatol; 2017 Feb; 66(2):355-362. PubMed ID: 27693539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 expression in hepatocellular carcinoma, cirrhosis and chronic hepatitis in the United States.
    Pazirandeh S; Khettry U; Gordon FD; Resnick RH; Murray JE; Sheth SG
    Dig Dis Sci; 2007 Jan; 52(1):220-7. PubMed ID: 17160481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma: status in the era of liver transplantation.
    Singhal A; Jabbour N
    J Okla State Med Assoc; 2009 Dec; 102(12):355-61. PubMed ID: 20131731
    [No Abstract]   [Full Text] [Related]  

  • 6. Onset of hepatocellular carcinoma in a non-cirrhotic patient affected with haemochromatosis.
    Tomao S; Romiti A; Mozzicafreddo A; Raffaele M; Zullo A; Antonaci A
    Oncol Rep; 1998; 5(3):723-5. PubMed ID: 9538184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors of hepatocellular carcinoma in Germany: hepatitis B or liver cirrhosis?
    Röckelein G; Hecken-Emmel M
    Hepatogastroenterology; 1988 Aug; 35(4):151-7. PubMed ID: 2846418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology of liver cirrhosis and hepatocellular carcinoma. Recent studies by Japanese workers.
    Mori W; Machinami R
    Acta Pathol Jpn; 1982; 32 Suppl 1():133-43. PubMed ID: 6196936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the risk of hepatitis B-related cirrhosis combined with type 2 diabetes mellitus for the occurrence of primary hepatocellular carcinoma].
    Zhang LL; Li YF; Zhang C; Wu XF; Ma Y; Li L
    Zhonghua Gan Zang Bing Za Zhi; 2019 Oct; 27(10):788-792. PubMed ID: 31734994
    [No Abstract]   [Full Text] [Related]  

  • 11. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
    Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
    Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.
    Tanabe KK; Lemoine A; Finkelstein DM; Kawasaki H; Fujii T; Chung RT; Lauwers GY; Kulu Y; Muzikansky A; Kuruppu D; Lanuti M; Goodwin JM; Azoulay D; Fuchs BC
    JAMA; 2008 Jan; 299(1):53-60. PubMed ID: 18167406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: frequency of surveillance and survival in hepatocellular carcinoma.
    Senussi NH; Kowdley KV
    Aliment Pharmacol Ther; 2018 Jul; 48(2):228-229. PubMed ID: 29939416
    [No Abstract]   [Full Text] [Related]  

  • 14. NASH and HCC.
    Page JM; Harrison SA
    Clin Liver Dis; 2009 Nov; 13(4):631-47. PubMed ID: 19818310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: hepatocellular carcinoma in non-cirrhotic NASH-a troubling reality.
    Boyle M; Anstee QM
    Aliment Pharmacol Ther; 2018 Nov; 48(9):1021-1023. PubMed ID: 30318679
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: NAFLD-related hepatocellular carcinoma - increasing or not? With or without cirrhosis?
    Balakrishnan M; El-Serag HB
    Aliment Pharmacol Ther; 2018 Feb; 47(3):437-438. PubMed ID: 29314126
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
    Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. May plasma cholesterol level be considered a neoplastic marker in liver disease from cirrhosis to hepatocellular carcinoma?
    Venturini I; Amedei R; Modonesi G; Cosenza R; Miglioli L; Cioni G; Zeneroli ML
    Ital J Gastroenterol Hepatol; 1999; 31(1):61-5. PubMed ID: 10091105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression to cirrhosis, hepatocellular carcinoma and liver-related mortality in chronic hepatitis B patients in Italy.
    Ieluzzi D; Covolo L; Donato F; Fattovich G
    Dig Liver Dis; 2014 May; 46(5):427-32. PubMed ID: 24548819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk lesions in cirrhosis and development of hepatocellular carcinoma: an autopsy study.
    Nakanuma Y; Kanel GC; Doishita K; Ohta G; Peters RL
    Biomed Pharmacother; 1989; 43(2):127-33. PubMed ID: 2544232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.